Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetics and biology of prostate cancer
Guocan Wang, Di Zhao, Denise J. Spring, et al.
Genes & Development (2018) Vol. 32, Iss. 17-18, pp. 1105-1140
Open Access | Times Cited: 634

Showing 1-25 of 634 citing articles:

Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Irina Larionova, Gulnara Tuguzbaeva, Anastasia A. Ponomaryova, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 313
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
Lauren Brady, Michelle Kriner, Ilsa M. Coleman, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 225
Naringenin: A potential flavonoid phytochemical for cancer therapy
Mahzad Motallebi, Mohammed Bhia, Huda Fatima Rajani, et al.
Life Sciences (2022) Vol. 305, pp. 120752-120752
Closed Access | Times Cited: 193
Epidemiology and genomics of prostate cancer in Asian men
Yao Zhu, Miao Mo, Wei Yu, et al.
Nature Reviews Urology (2021) Vol. 18, Iss. 5, pp. 282-301
Closed Access | Times Cited: 186
Cancer in Africa: The Untold Story
Yosr Hamdi, Ines Abdeljaoued-Tej, Afzal Ali Zatchi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 123
Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p
Yu‐Zhong Yu, Daojun Lv, Chong Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 117
Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis
Weibo Zhong, Kaihui Wu, Zining Long, et al.
Microbiome (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 106
Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer
Juening Kang, Federico La Manna, Francesco Bonollo, et al.
Cancer Letters (2022) Vol. 530, pp. 156-169
Open Access | Times Cited: 95
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Qingmiao Shi, Chen Xue, Yifan Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 78
Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment
Nataša Kuštrimović, R Bombelli, Denisa Baci, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1511-1511
Open Access | Times Cited: 48
A Comprehensive Review and Androgen Deprivation Therapy and Its Impact on Alzheimer’s Disease Risk in Older Men with Prostate Cancer
Manisha Singh, Vinayak Agarwal, Pranav Pancham, et al.
Degenerative Neurological and Neuromuscular Disease (2024) Vol. Volume 14, pp. 33-46
Open Access | Times Cited: 27
The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy
Dechao Feng, Weizhen Zhu, Jie Wang, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 25
CircRNAs: Pivotal modulators of TGF-β signalling in cancer pathogenesis
Asif Ahmad Bhat, Gaurav Gupta, Rajiv Dahiya, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 277-287
Open Access | Times Cited: 16
Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
Timothy O. Adekoya, Ricardo M. Richardson
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4449-4449
Open Access | Times Cited: 134
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
Xiangyu Zhang
Cancer Communications (2019) Vol. 39, Iss. 1
Open Access | Times Cited: 128
Epidemiology, Staging and Management of Prostate Cancer
Adam Barsouk, Sandeep Padala, Anusha Vakiti, et al.
Medical Sciences (2020) Vol. 8, Iss. 3, pp. 28-28
Open Access | Times Cited: 125
Anti-Cancer Effects of Green Tea Polyphenols Against Prostate Cancer
Yasuyoshi Miyata, Yohei Shida, Tomoaki Hakariya, et al.
Molecules (2019) Vol. 24, Iss. 1, pp. 193-193
Open Access | Times Cited: 116
Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer
Di Zhao, Li Cai, Xin Lü, et al.
Cancer Discovery (2020) Vol. 10, Iss. 9, pp. 1374-1387
Open Access | Times Cited: 80
Metabolomics Biomarkers of Prostate Cancer: A Systematic Review
Marouane Kdadra, Sebastian Höckner, Hing Y. Leung, et al.
Diagnostics (2019) Vol. 9, Iss. 1, pp. 21-21
Open Access | Times Cited: 78
Cancer-associated fibroblast regulate proliferation and migration of prostate cancer cells through TGF-β signaling pathway
Dai-Yu Sun, Jiaqi Wu, Zhiheng He, et al.
Life Sciences (2019) Vol. 235, pp. 116791-116791
Closed Access | Times Cited: 78
CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers
Aaron Waddell, Haojie Huang, Daiqing Liao
Cancers (2021) Vol. 13, Iss. 12, pp. 2872-2872
Open Access | Times Cited: 71
Microbiota and prostate cancer
Alessandro Rizzo, Matteo Santoni, Veronica Mollica, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 1058-1065
Closed Access | Times Cited: 68
Applying artificial intelligence for cancer immunotherapy
Zhijie Xu, Xiang Wang, Shuangshuang Zeng, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3393-3405
Open Access | Times Cited: 64
Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens
Raphaëlle Servant, Michele Garioni, Tatjana Vlajnic, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 5, pp. 543-555
Open Access | Times Cited: 58
ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression
Ni Li, Qiuli Liu, Ying Han, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top